In other words, TXNIP promotes the expression of proinflammatory factors such as TNF and IL-1β but inhibits the expression of anti-inflammatory factors by affecting macrophage polarization, ultimately leading to RA (84). Here, IL1B is linked to rheumatoid arthritis.